AEQUUS PHARMACEUTICALS INC (AQS.CA) Stock Income Statement
TSX-V:AQS - TSX Venture Exchange - CA0076361033 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 413.20K | 254.90K | 1.38M | 2.71M | 2.59M | |||
| Cost Of Goods | 192.40K | 111.20K | 103.60K | 25.80K | N/A | |||
| Gross Profit | 220.90K | 143.70K | 1.28M | 2.69M | N/A | |||
| Operating Expenses | 2.71M | 2.96M | 3.77M | 4.06M | 3.14M | |||
| Research and Development | 0.00 | 301.30K | 168.70K | 296.90K | 54.60K | |||
| Selling, General, and Administrative Expenses | 2.57M | 2.52M | 3.48M | 3.63M | 2.87M | |||
| Operating Income | -2.49M | -2.82M | -2.50M | -1.37M | -545.40K | |||
| Interest Income/Expense | -233.30K | -144.40K | -145.30K | -442.10K | -519.30K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | 0.00 | -566.80K | 0.00 | 19.30K | |||
| Income Before Taxes | -2.68M | -2.96M | -3.21M | -1.81M | -1.05M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -2.68M | -2.96M | -3.21M | -1.81M | -1.05M | |||
| EBITDA | -2.35M | -2.68M | -2.37M | -1.24M | -334.40K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | |||
| Statistics | ||||||||
| Gross Profit Margin | 53.46% | 56.38% | 92.49% | 99.05% | N/A | |||
| Profit Margin | -647.56% | -1163.08% | -232.64% | -66.66% | -40.32% | |||
| Operating Profit Margin | -601.52% | -1106.43% | -181.04% | -50.37% | -21.04% | |||
All data in CAD